For Quick Alerts
ALLOW NOTIFICATIONS  
For Daily Alerts

Sun Pharma Rallies On BofA-ML Upgrade

|

Shares in Sun Pharma gained more than 2 percent to Rs 909, after BofA-ML upgraded the stock to "buy" from "neutral", raising its target price to Rs 1,070.

Sun Pharma Rallies On BofA-ML Upgrade
Sun Pharmaceutical Industries: Quotes, News
BSE 413.95BSE Quote3.05 (0.74%)
NSE 413.70NSE Quote2.55 (0.62%)
Shares in Sun Pharma have seen some buying support in the last few weeks after the rupee depreciated against the Dollar.
 

The stock had tumbled to a 52-week low of Rs 752, but, has recovered since. The drop was largely as a result of a poor set of quarterly numbers from the company.

Sun Pharma has over the last quarter seen its performance deteriorate largely on account of the consolidated figures after merging with Ranbaxy.

GoodReturns.in

Read more about: sun pharma ranbaxy
Story first published: Wednesday, August 19, 2015, 10:45 [IST]
Company Search
Get Instant News Updates
Enable
x
Notification Settings X
Time Settings
Done
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more